A 56-year-old man with a 14-year history of diabetes mellitus presents with poor vision, peripheral vascular disease, and mild proteinuria. Which of the following is the best monitor of the control of blood sugar levels in this patient?
First, I need to recall the standard methods for monitoring blood sugar control in diabetics. The main options are fasting blood glucose, random blood glucose, HbA1c, and maybe others like fructosamine. Since the question is about the best monitor, HbA1c is likely the answer here.
HbA1c measures the average blood glucose levels over the past 2-3 months. It's a standard test for long-term glucose control. The presence of complications like proteinuria (which suggests diabetic nephropathy) and peripheral vascular disease indicates chronic diabetes, so monitoring long-term control is crucial.
Looking at the options, the correct answer should be HbA1c. The other options might include fasting glucose, which is more for short-term monitoring and doesn't reflect long-term trends. Random glucose isn't as reliable. Fructosamine is another marker but reflects a shorter period (2-3 weeks).
Now, the distractors: Option A might be fasting blood glucose. While useful, it's a snapshot and doesn't account for daily variations. Option B could be random glucose, which is even less reliable. Option C might be fructosamine, which is shorter-term. Option D is likely HbA1c.
The clinical pearl here is that HbA1c is the gold standard for assessing long-term glycemic control, especially in patients with complications. The student should remember that HbA1c correlates with the risk of developing diabetic complications, making it essential for monitoring in such cases.
**Core Concept**
The best long-term monitor of blood glucose control in diabetes is HbA1c (glycated hemoglobin), which reflects average blood glucose levels over 2–3 months. It correlates with the risk of microvascular complications like retinopathy, nephropathy, and neuropathy.
**Why the Correct Answer is Right**
HbA1c measures the percentage of hemoglobin bound to glucose, reflecting sustained hyperglycemia. In this patient with diabetic complications (proteinuria, poor vision), it directly links to the risk of progression. Unlike daily glucose testing, it avoids variability from meals, stress, or transient hypoglycemia, making it the gold standard for therapeutic adjustments.
**Why Each Wrong Option is Incorrect**
**Option A:** Fasting blood glucose only assesses a single time point and misses postprandial spikes.
**Option B:** Random blood glucose is unreliable due to diurnal variation and meal effects.
**Option C:** Fructosamine measures short-term control (2–3 weeks) but lacks specificity for long-term trends.
**Clinical Pearl / High-Yield Fact**
Remember the ADA target HbA1c <7% for most diabetics to reduce complications. However, individualize goals for patients with comorbidities or hypoglycemia risk. The term "HbA1c" is a high-yield USMLE/AIIMS keyword.
**Correct Answer: D. HbA1c